STRATA Skin Sciences, Inc. (SSKN)

STRATA Skin Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.57	8.12	6.8	12.59	18.11	15.63
Cash & Cash Equivalents	6.57	8.12	6.8	12.59	18.11	15.63
Cash Growth	56.98%	19.47%	-46.01%	-30.51%	15.89%	-5.20%
Receivables	3.63	4.44	4.47	3.43	2.94	4.39
Inventory	2.7	2.67	3.1	3.49	3.44	3.03
Other Current Assets	0.34	0.31	0.69	0.46	0.33	0.51
Total Current Assets	13.24	15.54	15.05	19.97	24.83	23.56
Property, Plant & Equipment	13.23	12.4	10.93	7.52	6.52	6.68
Goodwill and Intangibles	13.34	13.84	26.2	18.89	15.15	16.76
Other Long-Term Assets	0.23	0.23	0.1	0.22	0.28	0.35
Total Long-Term Assets	26.81	26.47	37.22	26.62	21.95	23.79
Total Assets	40.05	42.02	52.27	46.59	46.78	47.34
Accounts Payable	3.59	3.34	3.43	2.82	2.76	1.88
Deferred Revenue	2.85	2.67	3.09	3.69	2.3	2.83
Current Debt	0.3	0.35	0.36	0.32	9.12	7.59
Other Current Liabilities	5.85	5.81	6.55	5.98	4.66	5.13
Total Current Liabilities	12.59	12.17	13.43	12.8	18.84	17.43
Long-Term Debt	16.24	15.28	8.09	7.71	1.76	1.08
Other Long-Term Liabilities	1.79	1.87	8.93	0.67	0.29	0.18
Total Long-Term Liabilities	18.03	17.15	17.02	8.38	2.05	1.26
Total Liabilities	30.62	29.33	30.44	21.18	20.89	18.69
Total Debt	16.54	15.63	8.44	8.03	10.88	8.67
Debt Growth	97.22%	85.20%	5.13%	-26.22%	25.57%	17.16%
Retained Earnings	-241.43	-238.06	-227.23	-221.68	-218.97	-214.56
Shareholders' Equity	9.43	12.69	21.83	25.41	25.89	28.65
Net Cash / Debt	-9.97	-7.52	-1.65	4.56	7.23	6.96
Net Cash / Debt Growth	-	-	-	-36.97%	3.83%	-23.40%
Net Cash Per Share	-2.84	-2.15	-0.47	1.34	2.15	2.18
Working Capital	0.65	3.37	1.63	7.17	5.99	6.12
Book Value Per Share	2.69	3.63	6.29	7.46	7.70	8.96

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).